{"id":381112,"date":"2020-11-13T16:18:33","date_gmt":"2020-11-13T21:18:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=381112"},"modified":"2020-11-13T16:18:33","modified_gmt":"2020-11-13T21:18:33","slug":"regeneron-announces-investor-conference-presentations-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/","title":{"rendered":"Regeneron Announces Investor Conference Presentations"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>TARRYTOWN,\u00a0N.Y., <span class=\"xn-chron\">Nov. 13, 2020<\/span> \/PRNewswire\/ &#8212;\u00a0Regeneron Pharmaceuticals, Inc. (NASDAQ: <b>REGN<\/b>) will webcast management participation as follows:<\/p>\n<ul type=\"disc\">\n<li>Evercore ISI 3<sup>rd<\/sup> Annual HealthCONx Conference at 10:30 a.m. EST on <span class=\"xn-chron\">Tuesday, December 1, 2020<\/span><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <span class=\"xn-person\">Piper Sandler<\/span> 32<sup>nd<\/sup> Annual Virtual Healthcare Conference at 8:00 a.m. EST on <span class=\"xn-chron\">Wednesday, December 2, 2020<\/span><\/li>\n<\/ul>\n<p>The sessions may be accessed\u00a0from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2981417-1&amp;h=2252634147&amp;u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__nam03.safelinks.protection.outlook.com_-3Furl-3Dhttps-253A-252F-252Finvestor.regeneron.com-252Fevents-2Dand-2Dpresentations-26data-3D02-257C01-257Csitesupport-2540cision.com-257C9e8c3fea075f41183d9908d86c8cf3fa-257C887bf9ee3c824b88bcb280d5e169b99b-257C1-257C1-257C637378699941853637-26sdata-3D9-252F2Z0fqj-252FyTYrvd-252BFlXUcD8Bd5XIGkwq7yO2MDbtFTs-253D-26reserved-3D0%26d%3DDwMGaQ%26c%3Dsb6gdlHSSEAKVs7mNNqH8g%26r%3DNOkxivRH4romCTuroPlvrQ-6dVwANp5jyJDQZMVem4A%26m%3DqYt3LRj2xhqSwkCIm6PkHGTQMlubB2lNCmNdgHpDkhU%26s%3DH2YWLsPeUEC_BhIZS03UbXuscEtY80kiR7aiqWyEg1c%26e%3D&amp;a=https%3A%2F%2Finvestor.regeneron.com%2Fevents-and-presentations\" rel=\"nofollow noopener noreferrer\">https:\/\/investor.regeneron.com\/events-and-presentations<\/a>.\u00a0 Replays of the webcasts will be archived on the Company&#8217;s website for at least 30 days.<\/p>\n<p>\n        <b>About<\/b>\u00a0<b>Regeneron <br \/><\/b>Regeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to eight FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases.<\/p>\n<p>Regeneron is accelerating and improving the traditional drug development process through our proprietary\u00a0<i>VelociSuite<sup>\u00ae<\/sup><\/i>\u00a0technologies, such as\u00a0<i>VelocImmune<sup>\u00ae<\/sup><\/i>, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.<\/p>\n<p>For additional information about the company, please visit\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2981417-1&amp;h=272810422&amp;u=http%3A%2F%2Fwww.regeneron.com%2F&amp;a=www.regeneron.com\" rel=\"nofollow noopener noreferrer\">www.regeneron.com<\/a>\u00a0or follow @Regeneron on Twitter.<\/p>\n<p>\n        <b>Contact Information:<br \/><\/b>Investor Relations\u00a0\u00a0<br \/><span class=\"xn-person\">Justin Holko<\/span><br \/>914.847.7786\u00a0<br \/><a target=\"_blank\" href=\"mailto:justin.holko@regeneron.com\" rel=\"nofollow noopener noreferrer\">justin.holko@regeneron.com<\/a>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY91372&amp;sd=2020-11-13\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/regeneron-announces-investor-conference-presentations-301172851.html\">http:\/\/www.prnewswire.com\/news-releases\/regeneron-announces-investor-conference-presentations-301172851.html<\/a><\/p>\n<p>SOURCE  Regeneron Pharmaceuticals<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY91372&amp;Transmission_Id=202011131615PR_NEWS_USPR_____NY91372&amp;DateId=20201113\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire TARRYTOWN,\u00a0N.Y., Nov. 13, 2020 \/PRNewswire\/ &#8212;\u00a0Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: Evercore ISI 3rd Annual HealthCONx Conference at 10:30 a.m. EST on Tuesday, December 1, 2020 Piper Sandler 32nd Annual Virtual Healthcare Conference at 8:00 a.m. EST on Wednesday, December 2, 2020 The sessions may be accessed\u00a0from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com\/events-and-presentations.\u00a0 Replays of the webcasts will be archived on the Company&#8217;s website for at least 30 days. About\u00a0Regeneron Regeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Regeneron Announces Investor Conference Presentations&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-381112","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Regeneron Announces Investor Conference Presentations - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regeneron Announces Investor Conference Presentations - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire TARRYTOWN,\u00a0N.Y., Nov. 13, 2020 \/PRNewswire\/ &#8212;\u00a0Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: Evercore ISI 3rd Annual HealthCONx Conference at 10:30 a.m. EST on Tuesday, December 1, 2020 Piper Sandler 32nd Annual Virtual Healthcare Conference at 8:00 a.m. EST on Wednesday, December 2, 2020 The sessions may be accessed\u00a0from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com\/events-and-presentations.\u00a0 Replays of the webcasts will be archived on the Company&#8217;s website for at least 30 days. About\u00a0Regeneron Regeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to &hellip; Continue reading &quot;Regeneron Announces Investor Conference Presentations&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-13T21:18:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY91372&amp;sd=2020-11-13\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Regeneron Announces Investor Conference Presentations\",\"datePublished\":\"2020-11-13T21:18:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-3\\\/\"},\"wordCount\":265,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY91372&amp;sd=2020-11-13\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-3\\\/\",\"name\":\"Regeneron Announces Investor Conference Presentations - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY91372&amp;sd=2020-11-13\",\"datePublished\":\"2020-11-13T21:18:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY91372&amp;sd=2020-11-13\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY91372&amp;sd=2020-11-13\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regeneron Announces Investor Conference Presentations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regeneron Announces Investor Conference Presentations - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/","og_locale":"en_US","og_type":"article","og_title":"Regeneron Announces Investor Conference Presentations - Market Newsdesk","og_description":"PR Newswire TARRYTOWN,\u00a0N.Y., Nov. 13, 2020 \/PRNewswire\/ &#8212;\u00a0Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: Evercore ISI 3rd Annual HealthCONx Conference at 10:30 a.m. EST on Tuesday, December 1, 2020 Piper Sandler 32nd Annual Virtual Healthcare Conference at 8:00 a.m. EST on Wednesday, December 2, 2020 The sessions may be accessed\u00a0from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com\/events-and-presentations.\u00a0 Replays of the webcasts will be archived on the Company&#8217;s website for at least 30 days. About\u00a0Regeneron Regeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to &hellip; Continue reading \"Regeneron Announces Investor Conference Presentations\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-13T21:18:33+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY91372&amp;sd=2020-11-13","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Regeneron Announces Investor Conference Presentations","datePublished":"2020-11-13T21:18:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/"},"wordCount":265,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY91372&amp;sd=2020-11-13","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/","name":"Regeneron Announces Investor Conference Presentations - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY91372&amp;sd=2020-11-13","datePublished":"2020-11-13T21:18:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY91372&amp;sd=2020-11-13","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY91372&amp;sd=2020-11-13"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Regeneron Announces Investor Conference Presentations"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381112","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=381112"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381112\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=381112"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=381112"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=381112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}